LRRFIP1 is a key regulator of EMT, and its repression inhibits migration and invasion in cancer cells, mediated by increased phosphorylation of β-catenin targeting it for destruction to reduce its nuclear localisation and decreasing the transcription of downstream EMT markers (Douchi et al., 2015). The gene discussed is LRRFIP1; the disease is cancer.